PTSD Trial, Recruiting (NCT06706323)

PTSD Trial, Recruiting NCT06706323 Sponsor: Roland von Känel Condition: PTSD

Printed from Voxsanity (voxsanity.com.au) — NCT06706323 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ptsd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are scheduled for a planned (non-emergency) heart bypass surgery, either on its own or combined with a heart valve procedure
Adults aged between 18 and 90 years, both men and women
People who can read and understand the German language well enough to follow the study materials
People who are willing and able to give written and signed consent to take part
People who are willing and able to follow the study procedures as required

Who may not be able to join:

People who show signs of significant cognitive difficulty (such as problems with memory or thinking), based on a short screening test used by the trial site
People who have a serious non-heart-related health condition that is likely to cause death within one year, such as advanced cancer that has spread through the body
People who are currently experiencing psychotic symptoms, have had a problem with substance use or dependence in the past 6 months, or are currently having thoughts of suicide — all assessed using specific questionnaires used by the trial site
People who need urgent or emergency heart bypass surgery rather than a planned procedure

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Omer Dzemali, Prof. Dr., Stadtspital Zürich Triemli, Klinik für Herzchirurgie, Birmensdorferstr. 497, 8063 Zurich, Switzerland

Phone: +41 (0)44 255 52 51

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06706323

Sponsor: Roland von Känel

Phase: Not Applicable

Status: Recruiting

Condition: PTSD

Trial contact: +41 (0)44 255 52 51

More information: https://clinicaltrials.gov/study/NCT06706323

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are scheduled for a planned (non-emergency) heart bypass surgery, either on its own or combined with a heart valve procedure
Adults aged between 18 and 90 years, both men and women
People who can read and understand the German language well enough to follow the study materials
People who are willing and able to give written and signed consent to take part
People who are willing and able to follow the study procedures as required

Who may not be able to join:

People who show signs of significant cognitive difficulty (such as problems with memory or thinking), based on a short screening test used by the trial site
People who have a serious non-heart-related health condition that is likely to cause death within one year, such as advanced cancer that has spread through the body
People who are currently experiencing psychotic symptoms, have had a problem with substance use or dependence in the past 6 months, or are currently having thoughts of suicide — all assessed using specific questionnaires used by the trial site
People who need urgent or emergency heart bypass surgery rather than a planned procedure

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Roland von Känel

Registry

ClinicalTrials.gov

Start date

25 November 2024

Est. completion

1 April 2027

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Patient Health Questionnaire (PHQ-9) score ≥10 (yes/no) at 6 weeks post-CABG

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov